Breaking News

New Patient Enrolled into InVivo Therapeutics' INSPIRE Study

By Business Wire | November 17, 2016

Surgery and implantation performed on the T9 neurologically complete patient approximately 36 hours after injury occurred.

InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) at Oregon Health & Science University (OHSU) in Portland, Oregon. Ahmed M. Raslan, M.D. and Jason J Chang, M.D., Assistant Professors of Neurological Surgery and study investigators, performed surgery and the implantation on the T9 neurologically complete patient approximately 36 hours after the injury occurred.
 
Mark Perrin, InVivo’s CEO and Chairman, said, “We are pleased that the patient is doing well and wish them continued recovery. We have nine patients enrolled and in follow up and, because we now have over 25 INSPIRE sites open, expect enrollment to increase in the coming months.”
 
For more information, please visit the company’s ClinicalTrials.gov registration site.

Related News:

Related Markets:

  • Rear View Mirror Reflections

    Rear View Mirror Reflections

    Michael Barbella, Managing Editor||March 20, 2017
    AAOS past president discusses his tenure leading the organization.

  • The Shift to Outpatient Total Joint Replacements

    The Shift to Outpatient Total Joint Replacements

    Roger Massengale, General Manager, Acute Pain, Halyard Health||March 15, 2017
    As physicians look to shift patients to a same-day surgical option, technology addresses pain management.

  • Thrombosis: Examining New Preventative Measures

    Thrombosis: Examining New Preventative Measures

    Anthony Kjenstad, Founder and President, Athletic Recovery and Performance||March 9, 2017
    A new, wearable, wrist-watch sized device could offer patients a convenient alternative to current options.

  • Testing Your Patience

    Testing Your Patience

    Mark Crawford, Contributing Writer||March 22, 2017
    Changing FDA guidance and new technologies make device testing a challenging proposition for medtech OEMs.

  • Out of Ideas

    Out of Ideas

    Michael Barbella, Managing Editor||March 22, 2017
    Cost pressures, specialization, and customized solutions are currently driving orthopedic R&D.

  • Made of Sterner Stuff

    Made of Sterner Stuff

    Sam Brusco, Associate Editor||March 22, 2017
    Orthopedic materials are challenged to migrate away from metal while retaining metallic strength.